日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Establishing the reference broth microdilution MIC method for cefepime-taniborbactam

建立头孢吡肟-他尼博巴坦的参考肉汤微量稀释法MIC测定方法

期刊:Journal of Clinical Microbiology
影响因子:5.4
doi:10.1128/jcm.00661-25
Belley, Adam; Cusick, Susan M; Pevear, Dan C; Koeth, Laura; DiFranco-Fisher, Jeanna; Kothari, Nimmi; Hawser, Stephen; Moeck, Greg
发表日期：2025
文献求助 收藏

The association between undetected heteroresistance and antibiotic treatment failure in complicated urinary tract infection.

未发现的异质性耐药与复杂性尿路感染中抗生素治疗失败之间的关联

期刊:
影响因子:
doi:10.1101/2025.03.11.25323422
Abbott Carter N, Dhillon Aditi, Timalsina Sushma, Furr Elise, Velicitat Patrick, Belley Adam, Narayanan Navaneeth, Kaye Keith S, Weiss David S
其它
发表日期：2025
文献求助 收藏

Third-Generation Cephalosporin-Resistant Enterobacterales Are Critical Priority Pathogens, Too!

耐第三代头孢菌素肠杆菌也是重点关注的病原体！

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/aac.00213-22
Kaye, Keith S; Belley, Adam
微生物学
发表日期：2022
文献求助 收藏

Sigmoid E(max) Modeling To Define the Fixed Concentration of Enmetazobactam for MIC Testing in Combination with Cefepime

采用 Sigmoid E(max) 模型确定恩美他唑巴坦与头孢吡肟联合用药进行 MIC 测试的固定浓度

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.00926-21
Knechtle, Philipp; Shapiro, Stuart; Morrissey, Ian; De Piano, Cyntia; Belley, Adam
发表日期：2021
文献求助 收藏

Pharmacokinetics-Pharmacodynamics of Enmetazobactam Combined with Cefepime in a Neutropenic Murine Thigh Infection Model

恩美他唑巴坦联合头孢吡肟在嗜中性粒细胞减少小鼠大腿感染模型中的药代动力学-药效学研究

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.00078-20
Bernhard, Fabian; Odedra, Rajesh; Sordello, Sylvie; Cardin, Rossella; Franzoni, Samantha; Charrier, Cédric; Belley, Adam; Warn, Peter; Machacek, Matthias; Knechtle, Philipp
炎症/感染
细胞生物学
中性粒细胞
粒细胞
发表日期：2020
文献求助 收藏

Pharmacodynamics of Cefepime Combined with the Novel Extended-Spectrum-β-Lactamase (ESBL) Inhibitor Enmetazobactam for Murine Pneumonia Caused by ESBL-Producing Klebsiella pneumoniae

头孢吡肟联合新型超广谱β-内酰胺酶（ESBL）抑制剂恩美他唑巴坦治疗由产ESBL肺炎克雷伯菌引起的鼠肺炎的药效学研究

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.00180-20
Johnson, Adam; McEntee, Laura; Farrington, Nicola; Kolamunnage-Dona, Ruwanthi; Franzoni, Samantha; Vezzelli, Alberto; Massimiliano, Mameli; Knechtle, Philipp; Belley, Adam; Dane, Aaron; Drusano, George; Das, Shampa; Hope, William
肺炎
发表日期：2020
文献求助 收藏

Development of Broth Microdilution MIC and Disk Diffusion Antimicrobial Susceptibility Test Quality Control Ranges for the Combination of Cefepime and the Novel β-Lactamase Inhibitor Enmetazobactam

建立头孢吡肟与新型β-内酰胺酶抑制剂恩美他唑巴坦联合用药的肉汤微量稀释法MIC和纸片扩散法抗菌药物敏感性试验质量控制范围

期刊:Journal of Clinical Microbiology
影响因子:5.4
doi:10.1128/JCM.00607-19
Belley, Adam; Huband, Michael D; Fedler, Kelley A; Watters, Amy A; Flamm, Robert K; Shapiro, Stuart; Knechtle, Philipp
发表日期：2019
文献求助 收藏

Evaluation of Oritavancin Dosing Strategies against Vancomycin-Resistant Enterococcus faecium Isolates with or without Reduced Susceptibility to Daptomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model

在体外药代动力学/药效学模型中评估奥利万星对耐万古霉素粪肠球菌分离株（伴或不伴达托霉素敏感性降低）的给药策略

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.01873-17
Belley, Adam; Arhin, Francis F; Moeck, Greg
发表日期：2018
文献求助 收藏

Effects of Oritavancin on Coagulation Tests in the Clinical Laboratory

奥利万星对临床实验室凝血试验的影响

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.01968-16
Belley, Adam; Robson, Richard; Francis, John L; Adcock, Dorothy M; Tiefenbacher, Stefan; Rubino, Christopher M; Moeck, Greg; Sylvester, David; Dudley, Michael N; Loutit, Jeffery
发表日期：2017
文献求助 收藏

Comparative In Vitro Activities of Oritavancin, Dalbavancin, and Vancomycin against Methicillin-Resistant Staphylococcus aureus Isolates in a Nondividing State

奥利万星、达巴万星和万古霉素对非分裂状态下耐甲氧西林金黄色葡萄球菌分离株的体外活性比较

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.00169-16
Belley, Adam; Lalonde Seguin, David; Arhin, Francis; Moeck, Greg
发表日期：2016
文献求助 收藏